Dennis Wright
Vermogen: 976 805 $ op 31-10-2026
Vermogen: 976 805 $ op 31-10-2026
Dr. Dennis J.
Wright is a Chief Scientific Officer at Clinuvel Pharmaceuticals Ltd. Dr. Wright was previously employed as a Manager-Global Pharmacovigilance by Mayne Pharma Ltd. He received his undergraduate degree from The University of Sydney, a graduate degree from The University of Sydney and a doctorate degree from The University of Sydney.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-08-2025 | 192.312 ( 0,38% ) | 976 805 $ | 31-10-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Hoofd Techniek/Wetenschap/O&O | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Algemeen Adviseur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Clinuvel Pharmaceuticals Ltd.
Clinuvel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for patients with genetic, metabolic and life-threatening disorders | Health Technology |
The University of Sydney
The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau